Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Возможности самоконтроля гликемии в лечении сахарного диабета - Справочник поликлинического врача №9 (2014)
Возможности самоконтроля гликемии в лечении сахарного диабета
Е.В.Бирюкова. Возможности самоконтроля гликемии в лечении сахарного диабета. Справочник поликлинического врача. 2014; 9: 49–52.
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Полный текст
Список литературы
1. Khaled AA, Sekaran M, Ikram SI. Type 2 diabetes and vascular complications: A pathophysiologic view. Biomed Res 2010; 21 (2): 147–50.
2. Snell-Bergeon JK, Wadwa RP. Hypoglycemia, diabetes, and cardiovascular disease. Diabetes Technol Ther 2012; 14 (Suppl. 1): S51–S58.
3. Майоров А.Ю., Мельникова О.Г., Филиппов Ю.И. Вопросы самоконтроля гликемии в практике лечения сахарного диабета. Справ. поликлин. врача. 2012; 12: 32–6.
4. Holman RR, Paul SK, Bethel MA et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008; 359: 1577–89.
5. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Под ред. И.И.Дедова, М.В.Шестаковой. 6-й выпуск. М., 2013.
6. Farmer A, Wade A, Goyder E et al. Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial. BMJ 2007; 335: 13–8.
7. McGeoch G, Derry S, Moore RA. Self-monitoring of blood glucose in type-2 diabetes: what is the evidence? Diabetes Metab Res Rev 2007; 23: 423–40.
8. Neisser K, Weber C, Wenzel H, Schneider B. Costs of self-measurement of blood glucose (SMBG) regarding morbidity and mortality in type 2 diabetes in a reality of care setting (The ROSSO study No 6). The European Association for the Study of Diabetes. Abstract Volume 42st Annual Meeting, Copenhagen, Malmoe, 2006: p. 141.
9. Hansen MV, Pedersen-Bjergaard U, Heller SR et al. Frequency and motives of blood glucose self-monitoring in type 1 diabetes. Diabetes Res Clin Pract 2009; 85: 183–8.
10. ORIGIN Trial Investigators, Gerstein H., Yusuf S. et al. Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: the ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention). Am Heart J 2008; 155 (1): 26–32.
11. Clar C et al. Self-monitoring of blood glucose in type 2 diabetes: systematic review. Health Technol Assess 2010; 14 (12): 6.
12. O’Kane MJ, Bunting B, Copeland M et al. Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial. BMJ 2008; 336: 1174–7.
13. Kuo CY, Hsu CT, Ho CS et al. Accuracy and precision evaluation of seven self-monitoring blood glucose systems. Diabetes Technol Ther 2011; 13: 596–600.
14. International Organization for Standardization. In vitro diagnostic test systems. Requirements for blood-glucose monitoring system for self-testing in managing diabetes mellitus. Reference number ISO 15197:2003 (E). Geneva: International Organization for Standardization, 2003.
15. Polonsky WH, Fisher L, Schikman CH et al. Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes. Results from the structured testing program study. Diabetes Care 2011; 34: 262–7.
2. Snell-Bergeon JK, Wadwa RP. Hypoglycemia, diabetes, and cardiovascular disease. Diabetes Technol Ther 2012; 14 (Suppl. 1): S51–S58.
3. Майоров А.Ю., Мельникова О.Г., Филиппов Ю.И. Вопросы самоконтроля гликемии в практике лечения сахарного диабета. Справ. поликлин. врача. 2012; 12: 32–6.
4. Holman RR, Paul SK, Bethel MA et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008; 359: 1577–89.
5. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Под ред. И.И.Дедова, М.В.Шестаковой. 6-й выпуск. М., 2013.
6. Farmer A, Wade A, Goyder E et al. Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial. BMJ 2007; 335: 13–8.
7. McGeoch G, Derry S, Moore RA. Self-monitoring of blood glucose in type-2 diabetes: what is the evidence? Diabetes Metab Res Rev 2007; 23: 423–40.
8. Neisser K, Weber C, Wenzel H, Schneider B. Costs of self-measurement of blood glucose (SMBG) regarding morbidity and mortality in type 2 diabetes in a reality of care setting (The ROSSO study No 6). The European Association for the Study of Diabetes. Abstract Volume 42st Annual Meeting, Copenhagen, Malmoe, 2006: p. 141.
9. Hansen MV, Pedersen-Bjergaard U, Heller SR et al. Frequency and motives of blood glucose self-monitoring in type 1 diabetes. Diabetes Res Clin Pract 2009; 85: 183–8.
10. ORIGIN Trial Investigators, Gerstein H., Yusuf S. et al. Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: the ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention). Am Heart J 2008; 155 (1): 26–32.
11. Clar C et al. Self-monitoring of blood glucose in type 2 diabetes: systematic review. Health Technol Assess 2010; 14 (12): 6.
12. O’Kane MJ, Bunting B, Copeland M et al. Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial. BMJ 2008; 336: 1174–7.
13. Kuo CY, Hsu CT, Ho CS et al. Accuracy and precision evaluation of seven self-monitoring blood glucose systems. Diabetes Technol Ther 2011; 13: 596–600.
14. International Organization for Standardization. In vitro diagnostic test systems. Requirements for blood-glucose monitoring system for self-testing in managing diabetes mellitus. Reference number ISO 15197:2003 (E). Geneva: International Organization for Standardization, 2003.
15. Polonsky WH, Fisher L, Schikman CH et al. Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes. Results from the structured testing program study. Diabetes Care 2011; 34: 262–7.
Авторы
Е.В.Бирюкова
ГБОУ ВПО МГМСУ им. А.И.Евдокимова Минздрава России
ГБОУ ВПО МГМСУ им. А.И.Евдокимова Минздрава России
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.